Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

TMEM64 aggravates the malignant phenotype of glioma by activating the Wnt/β-catenin signaling pathway.

International journal of biological macromolecules - 1 Mar 2024

Yang Hui, Zhou Hanyu, Fu Minjie, Xu Hao, Huang Haoyu, Zhong Min, Zhang Mengying, Hua Wei, Lv Kun, Zhu Guoping

Abstract excerpt

Transmembrane protein 64 (TMEM64), a member of the family of transmembrane protein, is an α-helical membrane protein. Its precise role in various types of tumors, including glioma, is unclear. This study used immunohistochemical (IHC) staining, western blotting, and quantitative reverse transcription polymerase chain reaction (qRT-PCR) techniques to show that TMEM64 expression was significantly higher in glioma...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to beta Catenin
Share to Cell Line, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cell Proliferation

Share to Gene Expression Regulation, Neoplastic

Share to Glioma

Share to Phenotype

Share to Wnt Signaling Pathway

Source

Identifiers

PMID: 38232867
DOI: 10.1016/j.ijbiomac.2024.129332

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

TMEM64 aggravates the malignant phenotype of glioma by activating the Wnt/β-catenin signaling pathway.PMID 38232867Read ↗

TMEM65 promotes gastric tumorigenesis by targeting YWHAZ to activate PI3K-Akt-mTOR pathway and is a therapeutic targetSemantic proximity Read ↗

TMEM158 promotes the proliferation and migration of glioma cells via STAT3 signaling in glioblastomas.Semantic proximity Read ↗

ZNF326 promotes malignant phenotype of glioma by up-regulating HDAC7 expression and activating Wnt pathwaySemantic proximity Read ↗

The new oncogene transmembrane protein 60 is a potential therapeutic target in gliomaSemantic proximity Read ↗

Somatic CPEB4 and CPEB1 genes mutations spectrum on the prognostic predictive accuracy in patients with high-grade glioma and their clinical significance.Semantic proximity Read ↗

MicroRNA-671-3p promotes the proliferation and migration of glioma cells via targeting CKAP4Semantic proximity Read ↗

TGF-β induces GBM mesenchymal transition through upregulation of CLDN4 and nuclear translocation to activate TNF-α/NF-κB signal pathwaySemantic proximity Read ↗

Oncogenic roles of astrocyte elevated gene-1 (AEG-1) in osteosarcoma progression and prognosisSemantic proximity Read ↗

Histone demethylase KDM4C controls tumorigenesis of glioblastoma by epigenetically regulating p53 and c-MycSemantic proximity Read ↗

TCTP promotes glioma cell proliferation in vitro and in vivo via enhanced -catenin/TCF-4 transcriptionSemantic proximity Read ↗

TRIM31 enhances chemoresistance in glioblastoma through activation of the PI3K/Akt signaling pathwaySemantic proximity Read ↗

G-protein Coupled Receptor 34 Promotes Gliomagenesis by Inducing Proliferation and Malignant Phenotype via TGF-Beta/Smad Signaling Pathway.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.